IN-B009 / Korea Kolmar - LARVOL DELTA

Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) (clinicaltrials.gov) - P1; N=40; Recruiting; Sponsor: HK inno.N Corporation

Clinical • New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases